glp-1 cardiovascular outcomes news today Patients with diabetes who remained on drugs had lower risk New Science Suggests Semaglutide Improves

doi: 10.1111/dom.12932 [DOI] [PMC free article] [PubMed] [Google Scholar] 241

FDAs April 1 example appears directed at that post-shortage playbook and signals that the agency may view many semaglutide-plus-additive products as remaining essentially copies, absent robust, individualized clinical justification

Report No.: NCT05390892

What HRT can offer Prescription hormone replacement therapy delivers estrogen, which can be taken as a pill, capsule, or through the skin via patch, gel, or spray

The goal is not a number on a scale

Ania Jastreboff, an obesity medicine physician scientist at Yale University School of Medicine/Yale School of Medicine, co-Director of the Yale Center for Weight Management and the lead author on the phase 2 study, said that the results were striking and concluded that Retatrutide holds promise for substantial weight reduction in adults with obesity over a 48-week period